Savic Miloje, Dembinski Jennifer L, Kim Yohan, Tunheim Gro, Cox Rebecca J, Oftung Fredrik, Peters Bjoern, Mjaaland Siri
Department of Bacteriology and Immunology, Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway.
K. G. Jebsen Centre for Influenza Vaccine Research, Oslo University Hospital, Oslo, Norway.
Immunology. 2016 Feb;147(2):165-77. doi: 10.1111/imm.12548. Epub 2015 Dec 8.
Pre-existing human CD4(+) and CD8(+) T-cell-mediated immunity may be a useful correlate of protection against severe influenza disease. Identification and evaluation of common epitopes recognized by T cells with broad cross-reactivity is therefore important to guide universal influenza vaccine development, and to monitor immunological preparedness against pandemics. We have retrieved an optimal combination of MHC class I and class II restricted epitopes from the Immune Epitope Database (www.iedb.org), by defining a fitness score function depending on prevalence, sequence conservancy and HLA super-type coverage. Optimized libraries of CD4(+) and CD8(+) T-cell epitopes were selected from influenza antigens commonly present in seasonal and pandemic influenza strains from 1934 to 2009. These epitope pools were used to characterize human T-cell responses in healthy donors using interferon-γ ELISPOT assays. Upon stimulation, significant CD4(+) and CD8(+) T-cell responses were induced, primarily recognizing epitopes from the conserved viral core proteins. Furthermore, the CD4(+) and CD8(+) T cells were phenotypically characterized regarding functionality, cytotoxic potential and memory phenotype using flow cytometry. Optimized sets of T-cell peptide epitopes may be a useful tool to monitor the efficacy of clinical trials, the immune status of a population to predict immunological preparedness against pandemics, as well as being candidates for universal influenza vaccines.
预先存在的人类CD4(+)和CD8(+) T细胞介导的免疫可能是预防严重流感疾病的一种有用的保护相关指标。因此,鉴定和评估具有广泛交叉反应性的T细胞识别的共同表位对于指导通用流感疫苗的开发以及监测针对大流行的免疫准备情况非常重要。我们通过定义一个取决于流行率、序列保守性和HLA超型覆盖率的适应度评分函数,从免疫表位数据库(www.iedb.org)中检索了MHC I类和II类限制性表位的最佳组合。从1934年至2009年季节性和大流行性流感毒株中常见的流感抗原中选择了优化的CD4(+)和CD8(+) T细胞表位文库。这些表位库用于通过干扰素-γ ELISPOT试验来表征健康供体中的人类T细胞反应。刺激后,诱导了显著的CD4(+)和CD8(+) T细胞反应,主要识别来自保守病毒核心蛋白的表位。此外,使用流式细胞术对CD4(+)和CD8(+) T细胞的功能、细胞毒性潜力和记忆表型进行了表型特征分析。优化的T细胞肽表位组可能是监测临床试验疗效、人群免疫状态以预测针对大流行的免疫准备情况的有用工具,也是通用流感疫苗的候选物。